The association between acute fatty liver of pregnancy and fatty acid oxidation disorders

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 34, Issue 1, 2005, Pages 87-92

  Jamerson, Patricia A ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Acute fatty liver of pregnancy; Fatty acid oxidation disorder; Genetics; Inborn errors of metabolism; Pregnancy

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE; LIVER ENZYME; FATTY ACID;

ACUTE DISEASE; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC RISK; HUMAN; LIVER DISEASE; MEDICAL PRACTICE; MEDICAL RESEARCH; MOLECULAR GENETICS; NEWBORN; NEWBORN SCREENING; PATHOPHYSIOLOGY; PREGNANCY DISORDER; PROGENY; RISK ASSESSMENT; THIRD TRIMESTER PREGNANCY; ADULT; COMORBIDITY; COMPARATIVE STUDY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FETOMATERNAL TRANSFUSION; INCIDENCE; METABOLISM; OXIDATION REDUCTION REACTION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW;

ACUTE DISEASE; ADULT; COMORBIDITY; FATTY ACIDS; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MATERNAL-FETAL EXCHANGE; OXIDATION-REDUCTION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK ASSESSMENT;

EID: 15744381685     PISSN: 08842175     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884217504272800     Document Type: Article

References (38)

1. Barton, J. R., Sibai, B. M., Mabie, W. C., & Shanklin, D. R. (1990). Recurrent acute fatty liver of pregnancy. American Journal of Obstetrics and Gynecology, 163(2), 534-538.
2. Cashion, K. (1992). Liver disease in pregnancy. NAACOG's Clinical Issues in Perinatal and Women's Health Nursing, 3(3), 505-513.
3. Castro, M. A., Goodwin, T. M., Shaw, K. J., Ouzounian, J. G., & McGehee, W. G. (1996). Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. American Journal of Obstetrics and Gynecology, 174, 211-216.
4. Engel, A. G., & Angelini, C. (1973). Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome. Science, 179(76), 899.
5. Hagenfeldt, N., Venizelos, N., & Dobeln, U. (1995). Clinical and biochemical presentation of long chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Journal of Inheritable Metabolic Disorders, 18, 245-248.
6. Ibdah, J. A., Bennett, M. J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H. F., et al. (1999). A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. New England Journal of Medicine, 340(22), 1723-1731.
7. Ibdah, J. A., Dasouki, M. J., & Strauss, A. W. (1999). Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Variable expressivity of maternal illness during pregnancy and unusual presentation with infantile cholestasis and hypocalcaemia. Journal of Inheritable Metabolic Disorders, 22(7), 811-814.
8. Ibdah, J. A., Yang, Z., & Bennett, M. J. (2000). Liver disease in pregnancy and fetal fatty acid oxidation defects. Molecular Genetics and Metabolism, 71(1-2), 182-189.
9. Ijlst, L., Ruiter, J. P. N., Hoovers, J. M. N., Jakobs, M. E., & Wanders, R. J. A. (1996). Common missense mutation G1523C in long-chain 3-hydroxyacyl-coA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosome localization of the mitochondrial trifunctional protein alpha subunit gene. Journal of Clinical Investigation, 98(4), 1028-1033.
10. Innes, A. M., Seargeant, L. E., Balachandra, K., Roe, C. R., Wanders, R. J. A., Ruiter, J. P. N., et al. (2000). Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatric Research, 47(1), 43-45.
11. Isaacs, J. D., Sims, H. F., Powell, C. K., Bennett, M. J., Hale, D. E., Treem, W. R., et al. (1996). Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency. Molecular characterization of a novel maternal mutant allele. Pediatric Research, 40(3), 393-398.
12. MacLean, M. A., Cameron, A. D., Cumming, G. P., Murphy, K., Mills, P., & Hilan, K. J. (1994). Recurrence of acute fatty liver of pregnancy. British Journal of Obstetrics and Gynaecology, 101(5), 453-454.
13. Maitra, A., Domiati-Saad, R., Yost, N., Cunningham, G., Rogers, B. B., & Bennett, M. J. (2002). Absence of the G1528C (E474Q) mutation in the alpha subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy. Pediatric Research, 51(5), 658-661.
14. Matern, D., Schehata, B. M., Shekhawa, P., Strauss, A. W., Bennett, M. J., & Rinaldo, P. (2001). Placental floor infarct complicating the pregnancy of a fetus with long chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism, 72(3), 265-268.
15. Nelson, J., Lewis, B., & Walters, B. N. (2000). The HELLP syndrome associated with fetal medium-chain acyl-CoA dehydrogenase deficiency. Journal of Inheritable Metabolic Disorders, 23(5), 518-519.
16. Pockros, P. J., Peters, R. L., & Reynolds, T. B. (1984). Idiopathic fatty liver of pregnancy findings in ten cases. Medicine, 63(1), 1-11.
17. Purdie, J. M., & Walters, B. N. (1988). Acute fatty liver of pregnancy. Clinical features and diagnosis. Australia New Zealand Obstetric and Gynecology, 28(1), 62-71.
18. Rakheja, D., Bennett, M. J., Foster, B. M., Domiati-Saad, R., & Rogers, B. B. (2002). Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta, 23(5), 447-450.
19. Reyes, H., Sandoval, L., Wainstein, A., Ribalta, J., Donoso, S., Smok, G., et al. (1994). Acute fatty liver of pregnancy: A clinical study of 12 episodes in 11 patients. Gut, 35(1), 101-106.
20. Riely, C. A. (1987). Acute fatty liver of pregnancy. Seminars in Liver Disease, 7(1), 47-54.
21. Rinaldo, P., Studinski, A. L., & Matern, D. (2001). Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation. Prenatal Diagnosis, 21, 52-54.
22. Roe, C. R., & Ding, J. (2001). Mitochondrial fatty acid oxidation disorders. In C. R. Scriver, A. L. Beaudet, W, S. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (8th ed., Vol. 2, pp. 2297-2318). New York: McGraw Hill.
23. Schoeman, M. N., Batey, R. G., & Wilcken, B. (1991). Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology, 100(2), 544-548.
24. Simpson, K. R., Luppi, C. J., & O'Brien-Abel, N. (1998). Acute fatty liver of pregnancy. Journal of Perinatal and Neonatal Nursing, 11(4), 35-44.
25. Sims, H. F., Brackett, J. C., Powell, C. K., Treem, W. R., Hale, D. E., Bennett, M. J., et al. (1995). The molecular basis of pediatric long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proceedings of the National Academy Science, 92(3), 841-845.
26. Snyder, R. R., & Hankins, G. D. V. (1986). Etiology and management of acute fatty liver of pregnancy. Clinics of Perinatology, 13(4), 813-825.
27. Standler, H. J., & Cadden, B. S. (1934). Acute yellow atrophy of the liver in pregnancy. American Journal of Obstetrics and Gynecology, 28, 61-69.
28. Strauss, A. W., Bennett, M. J., Rinaldo, P., Sims, H. F., O'Brien, L. K., Zhao, Y., et al. (1999). Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Seminars in Perinatology, 23(2), 100-112.
29. Treem, W. R. (2002). Mitochondrial fatty acid oxidation and acute fatty liver of pregnancy. Seminars in Gastrointestinal Disease, 13(1), 55-66.
30. Treem, W. R., Rinaldo, P., & Hale, D. E. (1994). Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-CoA deficiency. Hepatology, 19(2), 339-345.
31. Treem, W. R., Shoup, M. E., Hale, D. E., Bennett, M. J., Rinaldo, P., Millington, D. S., et al. (1996). Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme. A dehydrogenase deficiency. American Journal of Gastroenterology, 91(11), 2293-2300.
32. Tyni, T., Ekholm, E., & Pihko, H. (1998). Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme. A dehydrogenase deficiency. American Journal of Obstetrics and Gynecology, 178, 603-608.
33. Tyni, T., Palotie, A., Viinikka, L., Valanne, L., Salo, M., von Dobeln, U., et al. (1997). Long-chain 3-hydroxyacyl-coenzyme. A dehydrogenase deficiency with the G1528C mutation: Clinical presentation in 13 patients. Journal of Pediatrics, 130(1), 67-76.
34. Vigil-De Gracia, P. (2001). Acute fatty liver and HELLP syndrome: Two distinct pregnancy disorders. International Journal of Gynecology and Obstetrics, 73, 215-220.
35. Visconti, M., Manes, G., Giannattasio, F., & Uomo, G. (199S). Recurrence of acute fatty liver of pregnancy. Journal of Clinical Gastroenterology, 21(3), 243-245.
36. Watson, W, J., & Seeds, J. W. (1990). Acute fatty liver of pregnancy. Obstetrical and Gynecological Survey, 45(9), 585-593.
37. Wilcken, B., Leung, K. C., Hammond, J., Kamath, R., & Leonard, J. V. (1993). Pregnancy and fetal long chain 3-hydroxyacyl coenzyme. A dehydrogenase deficiency. Lancet, 341(8842), 407-408.
38. Yang, Z., Yamada, J., Zhao, Y., Strauss, A. W., & Ibdah, J. A. (2002). Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. Journal of the American Medical Association, 288(17), 2163-2166.